http://www.pivotalpointgroup.com/index.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/biotech.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/pharma.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/cgmp_calibration.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/risk_analysis.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/prha_approach.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/gamp_5.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/document_change_control.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/criticality_matrix.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/complexity_matrix.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/university-research.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/change_management.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/about_us.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/contact_us.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/anthony_shuker-_ph_d_.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/management_team.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/michael_connor.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/nolan_watson.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/jeffery_talka.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/operational_team.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/ron_mills.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/joey_moodley.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/duane_saltsgaver.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/eric_shulenberger-_ph_d_-_j_d_.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/drug_pipeline.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/new_indications.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/research_and_discovery.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/investigational_new_drug.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/drug_development.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/scale-up_and_launch.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/commercialization.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/cost_and_schedule.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/grant_proposals.html2011-10-26T16:02+00:00http://www.pivotalpointgroup.com/html/the_process.html2011-10-26T16:02+00:00